Why do men who receive finasteride have an increased prevalence of high-grade prostate cancer?

被引：0
作者：
Damian Greene
Tobias Page
机构：
[1] D Greene is a Professor,and Head of Department, and T Page is a Specialist Registrar in Urology at the Department of Urology
[2] a Consultant Urological Surgeon,undefined
[3] Sunderland Royal Hospital,undefined
[4] Sunderland,undefined
[5] UK.,undefined
来源：
Nature Clinical Practice Urology | 2008年 / 5卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：130 / 131
页数：1
相关论文
共 5 条
[1]  
Marberger M(2003)The clinical implications of the prostate cancer prevention trial BJU Int 92 667-671
[2]  
Akduman B(2006)The PCPT: new findings, new insights, and clinical implications for the prevention of prostate cancer Eur Urol Suppl 5 634-639
[3]  
Crawford ED(2006)Do 5α-reductase inhibitors alter prostate cancer detection and what are the implications Eur Urol Suppl 5 752-757
[4]  
Lucia MS(2006)Evidence for a biopsy derived grade artifact among larger prostate glands J Urol 175 505-509
[5]  
Kulkarni GS(undefined)undefined undefined undefined undefined-undefined
1